tiprankstipranks
Trending News
More News >
Chordia Therapeutics Inc. (JP:190A)
:190A
Japanese Market
Advertisement

Chordia Therapeutics Inc. (190A) Income Statement

Compare
2 Followers

Chordia Therapeutics Inc. Income Statement

Last quarter (Q4 2024), Chordia Therapeutics Inc.'s total revenue was ¥0.00. In Q4, Chordia Therapeutics Inc.'s net income was ¥-649.65M. See Chordia Therapeutics Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 24Sep 23Sep 22Sep 21
Total Revenue
¥ 0.00¥ 2.50B¥ 0.00¥ 800.00M
Gross Profit
¥ -4.09M¥ 2.50B¥ -3.15M¥ 800.00M
Operating Expenses
¥ 1.80B¥ 2.28B¥ 1.84B¥ 1.39B
Depreciation and Amortization
¥ 4.09M¥ 6.04M¥ 3.15M¥ 700.00K
EBITDA
¥ -1.82B¥ 218.10M¥ -1.77B¥ -687.06M
Operating Income
¥ -1.80B¥ 212.06M¥ -1.84B¥ -587.67M
Other Income/Expenses
¥ -23.31M¥ 13.70M¥ 67.47M¥ 169.19M
Pretax Income
¥ -1.82B¥ 225.76M¥ -1.78B¥ -525.21M
Net Income
¥ -1.83B¥ 223.34M¥ -1.78B¥ -527.11M
Per Share Metrics
Basic EPS
¥ -31.11¥ 3.96¥ -39.78¥ -15.08
Diluted EPS
¥ -31.11¥ 3.96¥ -39.78¥ -15.08
Weighted Average Shares Outstanding
58.73M 56.44M 44.72M 34.95M
Weighted Average Shares Outstanding (Diluted)
58.73M 56.44M 44.72M 34.95M
Currency in JPY

Chordia Therapeutics Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis